Targeting galectin-driven regulatory circuits in cancer and fibrosis

HIGHLIGHTS

• who: Karina V. Mariamp#x000F1 and o from the (UNIVERSITY) have published the research: Targeting galectin-driven regulatory circuits in cancer and fibrosis, in the Journal: (JOURNAL)
• what: The authors focus on the therapeutic relevance of galectins particularly 1 (GAL1) GAL3 and GAL9 to tumour progression and fibrotic diseases. The authors focus on the results of preclinical studies and clinical trials and highlight lessons learned from targeting galectins in a diverse group of disease states, including nonalcoholic steatohepatitis (NASH)19, idiopathic pulmonary fibrosis (IPF)22-24, as well as various malignancies11,17. The authors focus . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.